If you have tinnitus, you have probably heard some version of "there is nothing we can do, learn to live with it." That answer is outdated, but the honest picture is complicated. There is still no FDA approved drug for tinnitus. About 1 in 9 US adults live with this condition, and many carry it for decades: almost 3 in 10 have had symptoms for 15 years or more. Yet a lot of people never even bring it up with a doctor.
The good news is that the field finally started moving. The first device of its kind got FDA clearance in 2023, a university trial published strong results the same year, and dozens of studies are recruiting right now. Here is the full picture: what exists today, what is being tested, and why progress in this field took so long.
Looking for treatment options for Tinnitus?
Browse open Tinnitus clinical trials near you! We'll handle the follow-up.
What's approved and used today
Let's start with the uncomfortable truth: zero drugs are FDA-approved specifically for tinnitus. If a doctor prescribes medication to someone with tinnitus, it's usually aimed at something around the tinnitus, like poor sleep or anxiety, not the ringing sound itself.
Here's what doctors actually use, according to the National Institute on Deafness and Other Communication Disorders (NIDCD):
Sound therapy. This means playing background sound, anything from white noise machines to small wearable devices, to give the brain something else to focus on. According to NIDCD, this can work in three ways: it can mask the tinnitus sound, help you get used to it over time, or simply distract your attention elsewhere.
Hearing aids. Most people with tinnitus also have some hearing loss, and NIDCD lists hearing aids as one of the main options for them. Hearing aids amplify outside sounds the ear has stopped picking up on its own, which makes the internal ringing less noticeable by comparison.
Cognitive behavioral therapy (CBT). This doesn't turn the volume down on the sound itself. Instead, it works on the distress it causes, the sleep problems, trouble focusing, and mood issues that often come along with tinnitus.
Lenire, the first device of its kind. In March 2023, the FDA gave a special kind of approval (called De Novo clearance) to a device called Lenire, made by Neuromod Devices. It's the first "bimodal neuromodulation" device for tinnitus approved in the US, meaning it works through two channels at once: sound played through headphones, plus gentle electrical pulses delivered to the tongue. The idea is to retrain how the brain's hearing circuits behave. A controlled study of the device was published in a major scientific journal in 2024, and real-world results from US clinics followed in 2025.
That's the entire list of what's currently approved, which is exactly why so much attention in this field is on ongoing clinical trials.
What is tinnitus retraining therapy?
People hear this term and have no idea what it actually means. Tinnitus retraining therapy (usually just called TRT) combines counseling with sound therapy. The goal isn't to make the sound go away. It's to retrain your brain, both emotionally and physically, until you simply stop noticing the tinnitus, kind of like how you eventually stop noticing the hum of a refrigerator in your own kitchen. The counseling part deals with the "alarm" response your brain has to the sound, while the sound therapy part helps your brain get used to it. Audiologists typically deliver this over several months, not just a few weeks.
What researchers are studying now
Since there's no approved drug, tinnitus research looks pretty different from most other conditions. It's mostly focused on devices, brain stimulation, and behavioral programs, not pills.
The University of Michigan's dual-sense device. This is the most talked-about result in recent years. A team led by Susan Shore built a device that pairs sound with precisely timed electrical pulses on the skin, aimed at a specific type of tinnitus (called "somatic" tinnitus) where jaw or neck movement changes the sound you hear. In a study of 99 people, published in a major medical journal in June 2023, the real treatment beat the sound-only comparison group by a clear margin, and people said the sound itself actually got quieter. A company called Auricle is now working to bring the device to market, though it's not FDA approved yet.
Brain and nerve stimulation. Several studies are testing ways to calm down overactive hearing circuits in the brain from the outside, including magnetic brain stimulation and electrical stimulation of the vagus nerve (a major nerve running through the body). Some studies combine approaches directly: a University of California, Irvine study currently recruiting is testing sound and electrical stimulation together in 100 people. All of these rest on the same basic idea as Lenire and the Michigan device: if the brain is creating the phantom sound, the brain is where treatment needs to happen.
Apps and digital programs. A smartphone-based tinnitus therapy is being tested in a large trial in the UK, and mindfulness apps are also being studied, including one at the University of Colorado Denver specifically for children with severe tinnitus or misophonia (extreme sensitivity to certain sounds). Kids with tinnitus are a group that's barely been studied at all, so a trial built just for them is worth noting.
The few drug studies that do exist. One of the rare larger drug trials tests methylprednisolone (a steroid) injected through the eardrum, run by Leiden University Medical Center. Earlier-stage drug research is happening in the US too: a Phase 2 study at Wayne State University is enrolling 88 people to test a TNF-alpha treatment for tinnitus caused by blast exposure, and a study led by D. Bradley Welling, MD, PhD uses brain scans (fMRI) in 40 people to see what an IV medication called lidocaine does to tinnitus in the brain. That last one isn't really testing a treatment, it's more about understanding how tinnitus actually works in the brain.
Studies for specific groups. The VA runs tinnitus research specifically for veterans, since tinnitus is the most common service-related disability among them, including a 72-person study on somatic tinnitus run by the VA's research division. Other studies focus specifically on people with blast-related or pulse-matching tinnitus. Some studies don't test any treatment at all, they simply ask patients what they actually want out of treatment, which matters a lot in a field that hasn't agreed on what "success" even looks like.
Why tinnitus research took so long
Fair question: tinnitus has been around forever and is incredibly common, so why did the first approved device only show up in 2023? A few specific reasons.
The measurement problem. There's no scan or blood test that can detect tinnitus. Researchers rely on questionnaires (like the Tinnitus Functional Index) that ask how much the sound disrupts your daily life. These questionnaires work fine, but they're subjective, which makes trials harder to design and makes it harder to compare results across different studies.
The placebo problem. People who get the fake treatment in tinnitus trials often report real improvement too. Part of this is the normal placebo effect, and part of it is that tinnitus distress naturally goes up and down on its own. So any new treatment has to beat that shifting baseline, not just beat "nothing."
The subtype problem. Tinnitus isn't just one condition. Somatic, pulsatile, noise-induced, and blast-related tinnitus likely all need different treatment approaches. A treatment might work great for one type but fail when tested in a mixed group of patients, which is part of why newer studies recruit for very specific subtypes.
The representation problem. Minority groups are significantly less likely to bring up tinnitus with a doctor or get evaluated for it in the first place. And if someone never gets evaluated, they never get the chance to join a study, so research risks only capturing a narrower slice of people than actually live with the condition.
And drugs have failed here before, too. Otonomy's OTO-313, an injectable drug targeting a nerve-signaling receptor, didn't meet its goals in a Phase 2 trial and was discontinued in 2022. Failures like that pushed the field further toward devices and brain/nerve stimulation instead of pills.
Tinnitus affects more than your ears
The sound itself is only part of the picture. Tinnitus commonly comes along with hearing loss, poor sleep, trouble concentrating, anxiety, and depression. A large 2022 study found that tinnitus's overall impact on quality of life is comparable to migraine and chronic pain, which surprises a lot of people who think of it as just a minor annoyance. The somatic type specifically is linked to jaw and neck problems.
And the whole thing can become a self-feeding loop. Tinnitus is most noticeable in quiet environments, which means it shows up right at bedtime, and then poor sleep makes the next day's tinnitus even harder to tune out. That loop is exactly why CBT became such a key tool for what is, at its core, an ear-related problem. If tinnitus is affecting your sleep or mental health, that's worth bringing up with your doctor on its own, separate from the tinnitus itself.
What is pulsatile tinnitus, and is it dangerous?
Pulsatile tinnitus is the version that beats in time with your heartbeat, more of a whooshing or thumping sound than a ring. It's uncommon, showing up in only about 5 to 10 out of every 100 tinnitus cases, and it's treated as its own separate category because it usually has an actual physical cause that doctors can find. With regular tinnitus, there's rarely one specific thing to point to. But with pulsatile tinnitus, a thorough exam finds the cause more than 7 times out of 10, and it's almost always related to blood flow near the ear. Common causes include:
- Narrowing of an artery due to atherosclerosis (plaque buildup)
- Increased pressure inside the skull (the most common cause related to veins)
- Abnormal connections between arteries and veins, called dural arteriovenous fistulas, which show up in up to 20 out of every 100 pulse-matching cases
- Occasionally, a benign (non-cancerous) tumor at the base of the skull
Some of these causes are serious, which is why doctors treat pulsatile tinnitus as something to actively investigate, not something to just wait and watch. Sometimes a doctor can actually hear the sound using a stethoscope, and an ENT specialist may order imaging, usually a CT scan of the ear area or a CT scan of the blood vessels in the head and neck. Doctors also recommend a full hearing evaluation if your tinnitus is only in one ear, comes along with changes in hearing, or has lasted 6 months or longer. The good news: results are usually reassuring. Among people with one-sided tinnitus and uneven hearing loss, only about 2 out of 100 turn out to have a benign tumor on the hearing nerve. There's active research on pulsatile tinnitus too, including a study testing a stent (a small tube used to open up narrowed blood vessels) for the pulse-matching type.
Common myths about tinnitus
"Nothing can be done."
This is the most damaging myth out there. It's true there's no cure. But sound therapy, hearing aids, and CBT are all established tools that genuinely help manage it, there's one FDA-cleared device now, and active clinical trials are recruiting right now. "No cure" and "nothing helps" are two very different statements.
"Tinnitus is an old person's problem."
It does become more common with age, but about 1 in 10 young adults deal with it too. Noise exposure doesn't wait until retirement to catch up with you.
"Tinnitus is rare, it's just me."
About 1 in 9 US adults report having it, and roughly 1 in 7 adults worldwide experience it. What's actually rare is talking about it: a lot of people never even mention it to a doctor, and this is even less common among minority groups, who are less likely to bring it up or get it checked out at all.
"Tinnitus means you're going deaf."
Tinnitus and hearing loss often show up together, but tinnitus itself is a symptom, not a countdown to losing your hearing. Plenty of people have completely stable hearing while still dealing with ongoing tinnitus.
Types of tinnitus, and what care usually looks like
Tinnitus doesn't have a staging system the way some diseases do. Instead, care usually depends on the type you have and how much it's affecting your daily life.
Mild, subjective tinnitus. This is the most common situation: a ringing or buzzing sound that's noticeable but manageable. Typical care includes a hearing check, treating anything reversible (like earwax buildup), and reviewing any medications that might be making it worse. Often, that's all that's needed.
Bothersome tinnitus with hearing loss. When the sound starts getting in the way of sleep and focus, care usually adds hearing aids, sound therapy, or CBT, often through an audiologist. This is also where structured programs like tinnitus retraining therapy come into play, and where a lot of clinical trial recruitment happens.
Severe tinnitus. Roughly 1 in 50 adults worldwide deal with severe tinnitus. At this level, care tends to involve a team approach, audiology and mental health support working together rather than one after the other. Many device trials are specifically built for this group.
Pulsatile tinnitus. The type that beats in sync with your pulse follows a completely different path, as explained earlier, because doctors want to identify the underlying cause before even discussing how to manage it.
None of this is meant as personal treatment advice. It's a description of what typical care usually looks like, and your own plan should be worked out with your doctor.
How to find a tinnitus study
If you want to be part of where this field is going, AllClinicalTrials.com lists tinnitus studies recruiting across the US, from device trials to app-based programs to VA research. A couple of examples: a noninvasive device therapy trial in Miami, and a neurofeedback training study at the University of Illinois at Urbana-Champaign aimed at reducing tinnitus-related distress. You can browse studies by location and read what each one involves in plain language. The application takes about 5 minutes, and if a study nearby fits, the study team contacts you and walks you through the details before you decide anything. Participation is always voluntary, and eligibility varies by study.
Common questions
What is tinnitus, in simple terms? Tinnitus means hearing a sound that isn't actually coming from anywhere outside you, usually ringing, buzzing, hissing, or a roaring noise. It's a symptom, not a disease on its own, and it usually traces back to damage inside the ear, which causes the brain's hearing system to start generating a "phantom" sound on its own. It can happen in one ear, both ears, or feel like it's coming from inside your head.
What does tinnitus sound like? It's different for everyone. The sound might ring, buzz, roar, whistle, hum, click, hiss, or squeal. It can be soft or loud, low-pitched or high-pitched, and you might notice it in one ear, both ears, or somewhere inside your head. Some people hear it constantly, while others only notice it in a quiet room at night.
What is the Tinnitus Functional Index? The TFI is a standard questionnaire used in tinnitus research. It measures how much tinnitus is affecting your sleep, concentration, emotions, and daily life overall, and researchers use it to see whether a treatment actually helps lower that score.
What is the VA rating for tinnitus? The VA rates ongoing tinnitus at 10%, under a specific code (6260). That's a single flat rating, whether you hear the sound in one ear, both ears, or inside your head. Tinnitus is actually the most common service-connected disability among veterans receiving VA compensation, with more than 3 million people receiving benefits for it in fiscal year 2025. This is just the general rule, not advice about your personal claim, so it's worth talking to the VA or an accredited representative about your specific situation.